Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices.

Published in: Journal of clinical medicine (2022)

Inflammatory bowel diseases (IBD) are chronic relapsing diseases of the gastrointestinal tract of unknown origin, resulting from an aberrant immune response to microbial and gut-specific antigens in genetically susceptible patients [...].

Keyphrases

immune response
end stage renal disease
multiple sclerosis
newly diagnosed
ejection fraction
dendritic cells
prognostic factors
microbial community
peritoneal dialysis
rheumatoid arthritis
drug induced
inflammatory response
replacement therapy
patient reported